A citation-based method for searching scientific literature

Mônica de A Lima Gabbay. Arq Bras Endocrinol Metabol 2008
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes.
P R Galassetti, K Iwanaga, A M Pontello, F P Zaldivar, R L Flores, J K Larson. Am J Physiol Endocrinol Metab 2006
29
50

Utility of different measures of body fat distribution in children and adolescents.
S R Daniels, P R Khoury, J A Morrison. Am J Epidemiol 2000
124
50





Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control.
M Salerno, A Argenziano, S Di Maio, N Gasparini, S Formicola, G De Filippo, A Tenore. Diabetes Care 1997
58
50


Longitudinal data on growth and final height in diabetic children.
M V Du Caju, R P Rooman, L op de Beeck. Pediatr Res 1995
48
50

[Physiology of the GH-IGF axis].
Carlos Eduardo Martinelli, Rodrigo José Custódio, Manuel Hermínio Aguiar-Oliveira. Arq Bras Endocrinol Metabol 2008
11
50

Growth during childhood and final height in type 1 diabetes.
M Brown, M L Ahmed, K L Clayton, D B Dunger. Diabet Med 1994
73
50

[Dyslipidemias in type 1 diabetes: a current approach].
Alessandra S de Mattos Matheus, Roberta Arnoldi Cobas, Marília B Gomes. Arq Bras Endocrinol Metabol 2008
8
50

The role of diabetes duration, pubertal development and metabolic control in growth in children with type 1 diabetes mellitus.
R Luna, P Alvarez-Vázquez, E Hervás, A Casterás, L Pérez Méndez, C Páramo, R V García-Mayor. J Pediatr Endocrinol Metab 2005
7
50


Growth pattern in juvenile diabetes.
G Sterky. Acta Paediatr Scand 1967
17
50


Islet transplantation for brittle type 1 diabetes: the UIC protocol.
A Gangemi, P Salehi, B Hatipoglu, J Martellotto, B Barbaro, J B Kuechle, M Qi, Y Wang, P Pallan, C Owens,[...]. Am J Transplant 2008
117
50


Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
Damien Bresson, Lisa Togher, Evelyn Rodrigo, Yali Chen, Jeffrey A Bluestone, Kevan C Herold, Matthias von Herrath. J Clin Invest 2006
235
50

Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
Geoff Hale, Peppy Rebello, Ibrahim Al Bakir, Emma Bolam, Pawel Wiczling, William J Jusko, Evy Vandemeulebroucke, Bart Keymeulen, Chantal Mathieu, Annette-G Ziegler,[...]. J Clin Pharmacol 2010
33
50

Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus.
Nancy J Lee, Susan L Norris, Sujata Thakurta. Ann Fam Med 2010
17
50



Type 1 diabetes mellitus: etiology, presentation, and management.
Michael J Haller, Mark A Atkinson, Desmond Schatz. Pediatr Clin North Am 2005
75
50

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Kevan C Herold, Stephen Gitelman, Carla Greenbaum, Jennifer Puck, William Hagopian, Peter Gottlieb, Peter Sayre, Peter Bianchine, Emelita Wong, Vicki Seyfert-Margolis,[...]. Clin Immunol 2009
134
50

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
H H Parving, L Tarnow, F S Nielsen, P Rossing, T Mandrup-Poulsen, R Osterby, J Nerup. Diabetes Care 1999
55
50

Mecasermin.
Gillian M Keating. BioDrugs 2008
18
50

[Clinical effectiveness and tolerance of acarbose in the treatment of insulin-dependent diabetic patients (type I)].
F Escobar-Jiménez, A de Leiva, F Piñón, J Soler, J Tebar, M A Sancho, J L Herrera-Pombo, L F Pallardo, J A Vázquez, H de la Calle. Med Clin (Barc) 1993
5
50


Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.
Damien Bresson, Matthew Fradkin, Yulia Manenkova, Diane Rottembourg, Matthias von Herrath. Mol Ther 2010
32
50

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Nicole A Sherry, Wei Chen, Jake A Kushner, Mariela Glandt, Qizhi Tang, Sue Tsai, Pere Santamaria, Jeffrey A Bluestone, Anne-Marie B Brillantes, Kevan C Herold. Endocrinology 2007
139
50

Prevalence of type 1 diabetes mellitus in Karnal district, Haryana state, India.
Sanjay Kalra, Bharti Kalra, Amit Sharma. Diabetol Metab Syndr 2010
31
50

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.
G S Eisenbarth, S Srikanta, R Jackson, S Rabinowe, R Dolinar, T Aoki, M A Morris. Diabetes Res 1985
101
50

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Fred Whitehouse, Davida F Kruger, Mark Fineman, Larry Shen, James A Ruggles, David G Maggs, Christian Weyer, Orville G Kolterman. Diabetes Care 2002
188
50

Type 1 diabetes: etiology, immunology, and therapeutic strategies.
Tom L van Belle, Ken T Coppieters, Matthias G von Herrath. Physiol Rev 2011
584
50

Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.
Zhifang Yang, Zhiguang Zhou, Xia Li, Gan Huang, Jian Lin. Diabetes Res Clin Pract 2009
38
50

Acarbose in the treatment of type I diabetes.
P Hollander, X Pi-Sunyer, R F Coniff. Diabetes Care 1997
47
50

Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.
G Riccardi, R Giacco, M Parillo, S Turco, A A Rivellese, M R Ventura, S Contadini, G Marra, M Monteduro, F Santeusanio,[...]. Diabet Med 1999
24
50

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
95
50

Prevalence of known diabetes in Chennai City.
P V Asha Bai, B N Murthy, M Chellamariappan, M D Gupte, C V Krishnaswami. J Assoc Physicians India 2001
7
50

Etiology of type 1 diabetes.
John A Todd. Immunity 2010
320
50



The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.
Monique L Stone, Jan L Walker, Donald Chisholm, Maria E Craig, Kim C Donaghue, Patricia Crock, Donald Anderson, Charles F Verge. Pediatr Diabetes 2008
18
50

Anti-CD3 mAbs for treatment of type 1 diabetes.
Adam Kaufman, Kevan C Herold. Diabetes Metab Res Rev 2009
33
50

Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008.
Prasanna Kumar, Pushpa Krishna, Sanjay C Reddy, Mala Gurappa, S R Aravind, C Munichoodappa. J Indian Med Assoc 2008
33
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.